GLP-1 Drugs Reduce Breast Cancer Risk by 30%: What the June 2026 Research Means for Women
A June 2026 study found GLP-1 drugs like Ozempic lower breast cancer risk by 30% in women with obesity. A 40-year pharmacist explains the proposed mechanisms, who benefits most, and the natural lifestyle approaches that target the same protective pathways.